Objectives. To identify the endogenous lectins of the human bladder with th
e long-term goal of developing improved strategies for the treatment of int
erstitial cystitis and other bladder disorders.
Methods. Rabbit and human bladder sections were examined histochemically us
ing biotinylated neoglycoconjugates. Affinity chromatography of extracts of
rabbit bladder was performed on immobilized lactose to purify the galactos
e-binding protein.
Results. Biotinylated beta-D-galactose neoglycoconjugate showed the stronge
st specific staining of the rabbit and human bladder sections. The beta-D-N
-acetylglucosamine neoglycoconjugate also showed significant staining; the
alpha-L-fucose, alpha-D-mannose, alpha-D-N-acetylneuraminic acid, and alpha
-D-N-acetylgalactosamine neoglycoconjugates showed either very weak or no r
eaction. The strong Ca2+-independent binding of beta-D-galactose neoglycoco
njugates suggested the presence of galectins in rabbit and human bladder, A
ffinity chromatography of rabbit bladder extract on lactose gel yielded a g
alectin of about 30 kDa, consistent with the molecular biological data conf
irming the expression of galectin-3 in bladder.
Conclusions. Beta-D-galactose binds strongly and specifically to rabbit and
human bladder tissue sections. This information would be useful for the pu
rpose of modifying drugs used for the treatment of bladder disorders with l
igands of galactose-binding lectins to improve their retention in the bladd
er. (C) 1999, Elsevier Science Inc. All rights reserved.